Social Determinants of Health in Hepatobiliary Cancer Patients
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT06053333
- Status
- Recruiting
Conditions
- Malignant Hepatobiliary Neoplasm
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study evaluates barriers to receiving care and risks associated with developing cancer among patients diagnosed with hepatobiliary cancer.
Key Dates
- Start date
- Jul 17, 2023
- Status verified
- Feb 2026
- Primary completion
- Jul 17, 2028
- Completion
- Jul 17, 2028
Study Design
- Enrollment
- 400 participants (estimated)
Arms
- Arm: ObservationalPatients complete a questionnaire, undergo blood, urine, and buccal swab sample collection and have their medical records reviewed on study. Patients also undergo collection of clinically archived tissue samples on study.
Primary Outcome Measure
Percentage of patients reporting transportation barriers that affect medical care [ Time Frame: Baseline; up to 2 years ]
Central Contacts
- Clinical Trials Referral Office855-776-0015
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic in Rochester | Rochester | Minnesota | 55905 | Nguyen H. Tran, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site
Related Studies
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionRecruiting · Alliance for Clinical Trials in Oncology · Anchorage, Alaska
- Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary CancersRecruiting · Mayo Clinic · Rochester, Minnesota